The largest database of trusted experimental protocols

451 protocols using primescript rt reagent

1

Quantifying HSF1 Expression via qRT-PCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA and complementary DNA were isolated and prepared according to the protocol supplied with PrimeScript RT Reagent (TaKaRa, Japan) and PrimeScript RT Reagent (TaKaRa, Japan) according to the protocol supplied with the PrimeScript RT Reagent (TaKaRa, Japan). Expression of HSF1 was determined by qRT-PCR using Power SYBR Green PCR master mix (Applied Biosystems). Oligonucleotide sequences of the primer sets used were as follows: HSF1 (forward: 5’-TAATACGACTCACTATAGGG-3′, reverse: 5’-CTGGAATAGCTCAGAGGC-3′); GAPDH (forward: 5’-TGTGGGCATCAATGGATTTGG-3′ and reverse: 5’-ACACCATGTATTCCGGGTCAAT-3′).
+ Open protocol
+ Expand
2

Quantifying miR-1305 Expression in NSCLC

Check if the same lab product or an alternative is used in the 5 most similar protocols
The total RNA was extracted from NSCLC tissues and cell lines using the Trizol reagent (Invitrogen, Carlsbad, CA, USA) in accordance with the manufacturer’s instructions. Reverse transcription was performed with the PrimeScript RT Reagent (Takara, Japan). The expression of miR-1305 was quantified by quantitative PCR using the SYBR Green Master Mix (Tiangen Biotechnology, Beijing, China) on the 7500 Real-time PCR System (Applied Biosystems, Carlsbad, CA, USA). U6 RNA was detected as the internal control for normalization. The expression of miR-1305 was calculated using the 2−ΔΔCT method from three replicates. The primers used for the qPCR were designed as follows: miR-1305 forward: 5ʹ-ACAGGCCGGGACAAGTGCAATA and reverse, 5ʹ-GCTGTCAACGATACGCTACGTAACG; U6 forward, 5ʹ-AACGCTTCACGAATTTGCGT and reverse, 5ʹ-CTCGCTTCGGCAGCACA.
+ Open protocol
+ Expand
3

Quantitative Analysis of Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNAs were extracted using TriZol reagent (Invitrogen, Waltham, MA, USA). Transcription of cDNA was conducted using PrimeScript RT reagent (TaKaRa, Dalian, China). qRT-PCR was performed using SYBR Green PCR Kit (TaKaRa) on ABI 7300 system (Applied Biosystems, Waltham MA, USA). Primers were used as follows (5′ to 3′): SLC2A1, ATTGGCTCCGGTATCGTCAAC (Forward), GCTCAGATAGGACATCCAGGGTA (Reverse); PFKP, CGCCTACCTCAACGTGGTG (Forward), ACCTCCAGAACGAAGGTCCTC (Reverse); PKM, ATGTCGAAGCCCCATAGTGAA (Forward), TGGGTGGTGAATCAATGTCCA (Reverse); LDHA, ATGGCAACTCTAAAGGATCAGC (Forward), CCAACCCCAACAACTGTAATCT (Reverse); SNHG10, CCAGCTTAGATTCATTGATTCC (Forward), TTAAGTGCACCAGATGCTG (Reverse); TRIM66, GCCCTCTGTGCTACTTACTC (Forward), GCTGGTTGTGGGTTACTCTC (Reverse); miR-1271-5p, CAGCACTTGGCACCTAGCA (Forward), TATGGTTGTTCTCCTCTCTGTCTC (Reverse); U6, GCTTCGGCAGCACATATACTAAAAT (Forward), CGCTTCACGAATTTGCGTGTCAT (Reverse); β-actin, CGTCATACTCCTGCTTGCTG (Forward), GTACGCCAACACAGTGCTG (Reverse). The relative expression of target genes was analyzed using the 2−ΔΔCt method with U6 as the internal control for miR-1271-5p and β-actin for the other genes.
+ Open protocol
+ Expand
4

Quantitative Analysis of RNA Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from LUSC cells or tissues via TRIzol reagent (Invitrogen), and the cDNA was synthesized using the Primescript RT Reagent (TaKaRa). RT‐qPCR analysis was performed using SYBR®Premix Ex Taq™ Reagent (TaKaRa) through StepOne Plus Real‐Time PCR system (Applied Biosystems). GAPDH or U6 was, respectively, utilized to be lncRNA/mRNA and miRNA internal controls. The fold change in mRNA expression was calculated through the 2−ΔΔCt method.
+ Open protocol
+ Expand
5

Gene Expression Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the gene expression analysis, total RNA was extracted with the MiniBEST Universal RNA Extraction Kit (TaKaRa, Tokyo, Japan) or the miRNA Mini Kit (QIAGEN, Dusseldorf, Germany) in strict accordance with the instructions of the manufacturers. PrimeScript™ RT reagent (TaKaRa) was used for mRNA reverse transcription, and a miRNA First Strand cDNA Synthesis Tailing Reaction Kit (B532451, Sangon Biotech, Shanghai, China) was utilized for miRNA reverse transcription. After that, the TB Green™ Premix Ex Taq™ II kit (TaKaRa) was utilized to perform qRT‐PCR on a Real‐Time PCR Detection System (Bio‐Rad). U6 was utilized to normalize the miRNA expression levels. For the analysis of miRNA expression in EVs, samples were spiked with cel‐miR‐39 (miRB0000010‐3‐1, RIOBO) to control inter‐sample variability as described in previous studies.18 For mRNA analysis, β‐actin was employed to normalize the levels of genes of interest. The sequences of all primers used in the present study are shown in Table S1.
+ Open protocol
+ Expand
6

Quantifying miR-937-3p Expression in LUAD

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to determine the expression level of miR-937-3p in LUAD tissues and cells, total RNA was isolated from tissues and cells using RNA-Quick Purification Kit (YiShan bio, Shanghai, China) according to the instructions. CDNA was generated using total RNA and PrimeScriptRT reagent (Takara, Kusatsu, Japan), and qRT-PCR was performed on an ABI StepOne Plus system (Applied Biosystems, CA) using SYBR Green Master Mix II (Takara). U6 and GAPDH were used as the internal controls to normalize SOX11 and miR-937-3p. We used the 2 − ΔΔCT method to quantify the relative levels of miR-937-3p and SOX11 mRNA. Every sample was performed in triplicate.
+ Open protocol
+ Expand
7

Quantitative Real-Time PCR Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.) as previously described22 (link). The cDNA was synthesized by PrimeScript RT reagent (Takara Bio, Inc.). RT-qPCR was performed using SYBR Green Master Mix II (Takara Bio, Inc.) according to the manufacturer’s instructions. The expression levels of PRP3 and PRP31 were normalized to GAPDH. The expression levels of the genes investigated were calculated using the 2-∆∆Cq method. The primers used in the present work were as follows: PRP3 forward, 5′-GAGAATGCGAAGGAACAAGC-3′ and reverse, 5′-AGTCTTGCCGCTGTAGGTAA-3′; PRP31 forward, 5′-GGATCCATGTCTCTGGCAGATGAGCTCTTA-3′ and reverse, 5′-CCGCGGTCAGGTGGACATAAGGCCACTCTT-3′; GAPDH forward, 5′-ACATCGCTCAGACACCATG-3′ and reverse, 5′-TGTAGTTGAGGTCAATGAAGGG-3′.
+ Open protocol
+ Expand
8

Quantitative Real-Time PCR Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified total RNA was synthesized by using the PrimeScript RT reagent (Takara, Japan). QPCR was performed on an ABI 7500 PCR instrument using SYBR green reagents (Life Technologies, Carlsbad, CA) following the manufacturer's protocol. Each qPCR reaction (25 μ L) was comprised of 12.5 μ L 2 × SYBR Green qPCR Master Mix (Life Technologies, Carlsbad, CA), 1 μ L primer, 2 μ L cDNA, and 8.5 μ L H2O. The cycling was initiated by a single denaturing cycle of 95°C for 3 min followed by 40 cycles at 95°C for 20 s, 56-60°C for 20 s, and 72°C for 30 s. Specific primers used in this study were listed in Supplementary Table 1. Gene relative expression levels were normalized with β-actin by using 2−ΔΔCt value method [60 (link)]. The correlation between the results of RNA-seq and qPCR was calculated using Pearson's correlation method.
+ Open protocol
+ Expand
9

Genotypic Effects on SRA mRNA Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
To explore the effects of different genotypes of rs10463297 on the SRA mRNA expression, the relative levels of SRA mRNA was examine using SYBR-Green real-time quantitative PCR method in 82 samples obtained from cancer-free controls whose genotypic data were anonymous. Total RNA was isolated from blood plasma samples using TRIzol LS Reagent (Ambion). Then cDNA was synthesized with Primescript RT Reagent (Takara, Japan). The SRA primers used for quantitative real-time PCR were as follows: forward primer 5′- CAAGCGGAAGTGGAGATGGCGGAGC-3′ and reverse primer 5′- GCGAAGTGTGTAGGGAGCGGAGGCG-3′. For β-actin, as an internal reference gene, the primers used were 5′-AGAAAATCTGGCACCACACC-3′ and 5′-TAGCACAGCCTGGATAGCAA-3′ [35 (link)]. Amplification reactions were performed in a final volume of 20 μl containing10.0 μl Master mix, 150 ng cDNA, 1 μl primers. The reaction conditions of Real-time PCR were set at 95°C for 30s, followed by 40 cycles at 95°C for 5 s and 60°C for 30 s. All procedures were performed in triplicate. The expression of individual SRA mRNA expression measurements was calculated relative to expression of β-actin using the2−ΔCT method.
+ Open protocol
+ Expand
10

Quantification of miRNA and mRNA Expressions

Check if the same lab product or an alternative is used in the 5 most similar protocols
At 24 h post-transfection, cells were treated with TRIzol (Takara Bio, Inc., Otsu, Japan) to extract total RNA, which was reverse transcribed to first strand cDNA using Primescript RT Reagent (Takara Bio, Inc.). The expression levels of miR-675-3p (sense 5′-CGGAGAGGGCCCACAGTG-3′; anti-sense was an universal primer which was obtained from GeneCopoeia, USA), MMP2 (sense 5′-GCTGACGGTAAGGACGGACTC-3′; anti-sense 5′-CGTTGCCATTGAACAAGAAGG-3′), MMP9 (sense 5′-TGTGCTACAGGGAGAGATAAGA-3′; anti-sense 5′-GTGGGTGGAGCAGAGTAAATAA-3′) and E-cadherin (sense 5′-CTCAGTTGGAACAGGGTGAATA-3′; anti-sense 5′-GTGCAGGACACTCAAATCAAAG-3′) were examined using RT-qPCR in a Step one plus system (Roche Molecular Diagnostics, Pleasanton, CA, USA) using 2−ΔΔCq analysis. In this system, all reactions were performed in SybrGreen (ChamQ SYBR qPCR Master Mix; Vazyme, Piscataway, NJ, USA), in a volume of 20 ul containing 2 ul cDNA, according to the manufacturer's protocol. All reactions were performed in triplicate. The thermal cycling conditions included a step of 5 min at 95°C followed by 40 cycles of 95°C for 10 sec and 60°C for 30 sec. U6 was used as internal control. Final amounts of target in cells were determined as follows: Target amount=2−ΔΔCq, where ΔΔCq=[Cq (target)-Cq (U6)]sample-[Cq (target)-Cq (U6)]internal standard. Final amounts of target in tissues were determined as target amount=2−ΔΔCq (14 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!